Statistics for Entera Bio Ltd (id:5990 ENTX)
Valuation metrics
Market cap
77.35M
Enterprise value
70.74M
Trailing P/E (ttm)
-7.02
Forward P/E
-3.82
PEG ratio
-3.82
Price/Sales (ttm)
781.29
Price/Book (mrq)
11.54
Enterprise Value/Revenue
714.56
Enterprise Value/EBITDA
-7.72
Overview
Shares outstanding
36.83M
Float
25.85M
Shares short
62.96K
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
71.38K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
3.35
52-Week change
71.03%
Beta
1.59
50-Day moving average
1.84
200-Day moving average
1.90
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
0.00%
Operating margin
-7,192.86%
Operational effectiveness
Return on assets
-70.61%
Return on equity
-144.67%
Income statement
Revenue (ttm)
5.00
Revenue per share (ttm)
5.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-9,163,000.00
Net income to common (ttm)
-9,178,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
6.92M
Total cash per share (mrq)
3.00
Total debt (mrq)
309.00K
Total Debt/Equity (mrq)
4.79
Current ratio (mrq)
660.70%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
-7,968,000.00
Levered free cash flow (LFCF)
-6,336,875.00